MATTIOLI, IRENE
 Distribuzione geografica
Continente #
NA - Nord America 2.435
AS - Asia 2.317
EU - Europa 2.033
SA - Sud America 280
AF - Africa 128
OC - Oceania 95
Continente sconosciuto - Info sul continente non disponibili 1
Totale 7.289
Nazione #
US - Stati Uniti d'America 2.364
RU - Federazione Russa 818
CN - Cina 637
SG - Singapore 585
IT - Italia 402
HK - Hong Kong 261
BR - Brasile 208
KR - Corea 202
VN - Vietnam 168
IE - Irlanda 126
FR - Francia 114
GB - Regno Unito 109
DE - Germania 91
SE - Svezia 86
AU - Australia 85
IN - India 81
FI - Finlandia 78
TR - Turchia 73
CA - Canada 47
BD - Bangladesh 41
CH - Svizzera 41
NL - Olanda 41
ID - Indonesia 38
JP - Giappone 38
JO - Giordania 31
PL - Polonia 25
ZA - Sudafrica 25
PH - Filippine 23
CL - Cile 20
ES - Italia 20
AR - Argentina 17
MM - Myanmar 17
BE - Belgio 15
KE - Kenya 15
PK - Pakistan 15
UG - Uganda 14
IQ - Iraq 13
MX - Messico 13
NG - Nigeria 13
AE - Emirati Arabi Uniti 11
EC - Ecuador 11
ET - Etiopia 11
SA - Arabia Saudita 10
AT - Austria 9
IR - Iran 9
MY - Malesia 9
NP - Nepal 9
GR - Grecia 8
NZ - Nuova Zelanda 8
PT - Portogallo 8
BJ - Benin 7
MW - Malawi 7
RO - Romania 7
TH - Thailandia 7
TW - Taiwan 7
CO - Colombia 6
EG - Egitto 6
LT - Lituania 6
MA - Marocco 6
CZ - Repubblica Ceca 5
GH - Ghana 5
LB - Libano 5
NO - Norvegia 5
PY - Paraguay 5
UA - Ucraina 5
VE - Venezuela 5
AM - Armenia 4
CI - Costa d'Avorio 4
LI - Liechtenstein 4
PE - Perù 4
SN - Senegal 4
UZ - Uzbekistan 4
BO - Bolivia 3
DZ - Algeria 3
HU - Ungheria 3
KH - Cambogia 3
LK - Sri Lanka 3
TN - Tunisia 3
DK - Danimarca 2
DO - Repubblica Dominicana 2
GT - Guatemala 2
HN - Honduras 2
IL - Israele 2
IM - Isola di Man 2
KG - Kirghizistan 2
PA - Panama 2
PG - Papua Nuova Guinea 2
ZM - Zambia 2
AF - Afghanistan, Repubblica islamica di 1
AL - Albania 1
AZ - Azerbaigian 1
BY - Bielorussia 1
CW - ???statistics.table.value.countryCode.CW??? 1
CY - Cipro 1
GD - Grenada 1
GE - Georgia 1
JM - Giamaica 1
KZ - Kazakistan 1
MZ - Mozambico 1
NI - Nicaragua 1
Totale 7.281
Città #
Santa Clara 697
Singapore 427
Ashburn 415
Hefei 228
Hong Kong 221
Seoul 192
San Jose 131
Dublin 118
Chandler 98
Beijing 82
Ho Chi Minh City 68
Florence 67
New York 65
Los Angeles 54
Paris 45
Moscow 42
Helsinki 41
Melbourne 40
The Dalles 37
Fairfield 36
Hanoi 36
Lauterbourg 36
Munich 36
Buffalo 34
Mumbai 34
Bern 32
Dallas 28
Jakarta 27
Kent 27
Rome 26
Seattle 26
Milan 24
Council Bluffs 23
Tokyo 23
Shanghai 22
Warsaw 21
Altamura 20
Lappeenranta 20
Lawrence 20
Boston 17
Frankfurt am Main 17
Montreal 17
São Paulo 17
Turku 17
Woodbridge 17
Bengaluru 16
Istanbul 16
London 16
Princeton 15
Johannesburg 14
Perth 14
Santiago 14
Wilmington 14
Houston 13
Sydney 13
Ann Arbor 12
Chicago 12
Abuja 11
Kampala 11
Bari 10
Chennai 10
Orem 10
Sanliurfa 10
Addis Ababa 9
Brooklyn 9
Brussels 9
Cambridge 9
San Diego 9
Toronto 9
Auckland 8
Gold Coast 8
Kızıltepe 8
Lahore 8
Nairobi 8
Stockholm 8
Boardman 7
Cotonou 7
Genoa 7
Guangzhou 7
Miami 7
Riyadh 7
Vienna 7
Yubileyny 7
Al Ain City 6
Amman 6
Amsterdam 6
Ankara 6
Atlanta 6
Barnet 6
Brisbane 6
Manchester 6
Pamplona 6
Pune 6
Turin 6
Accra 5
Bangkok 5
Belém 5
Bogotá 5
Brasília 5
Cairo 5
Totale 4.206
Nome #
World report on the health of refugees and migrants 832
Adalimumab effectively controls both anterior and posterior noninfectious uveitis associated with systemic inflammatory diseases: focus on Behçet’s syndrome 260
Benralizumab for eosinophilic granulomatosis with polyangiitis: a retrospective, multicentre, cohort study 243
Management of pregnancy in autoimmune rheumatic diseases: maternal disease course, gestational and neonatal outcomes and use of medications in the prospectiveItalian P-RHEUM.it study 188
Antihypertensive treatment changes and related clinical outcomes in older hospitalized patients 182
Non-anti TNFα biologic agents for noninfectious uveitis associated with systemic inflammatory diseases: a systematic review 181
Mepolizumab for Eosinophilic Granulomatosis with Polyangiitis (EGPA): a European multicenter observational study 181
Prevalence and clinical associations of ultrasound-confirmed enthesitis in systemic lupus erythematosus 177
Efficacy and safety of infliximab or adalimumab in severe mucocutaneous Behçet's syndrome refractory to traditional immunosuppressants: a 6-month, multicentre, randomised controlled, prospective, parallel group, single-blind trial 174
Comparison of treatments for the prevention of fetal growth restriction in obstetric antiphospholipid syndrome: a systematic review and network meta-analysis 174
What changed in the Italian internal medicine and geriatric wards during the lockdown 163
POS1212 SARS-CoV-2 INFECTION AMONG PATIENTS WITH BEHÇET’S SYNDROME 162
Hospitalisations Related to the Combination of ACE Inhibitors and/or Angiotensin Receptor Blockers with Diuretics and NSAIDs: A Post Hoc Analysis on the Risks Associated with Triple Whammy 161
Sequential rituximab and mepolizumab in eosinophilic granulomatosis with polyangiitis (EGPA): a European multicentre observational study 161
Neutrophil-mediated mechanisms of damage and in vitro protective effect of colchicine in non-vascular Behçet's syndrome 155
Risk of acute arterial and venous thromboembolic events in eosinophilic granulomatosis with polyangiitis (Churg–Strauss syndrome) 154
Erythrocyte oxidative stress and thrombosis 152
Development and implementation of the AIDA international registry for patients with Schnitzler's syndrome 152
Canakinumab as first-line biological therapy in Still's disease and differences between the systemic and the chronic-articular courses: Real-life experience from the international AIDA registry 150
Factor XI Inhibitors: perspectives in primary and secondary prevention of ischemic stroke 144
Development and implementation of the AIDA International Registry for patients with Behçet's disease 142
Validity of Machine Learning in Predicting Giant Cell Arteritis Flare After Glucocorticoids Tapering 140
Obstetric antiphospholipid syndrome is not associated with an increased risk of subclinical atherosclerosis 140
Mepolizumab versus benralizumab for eosinophilic granulomatosis with polyangiitis (EGPA): A European real-life retrospective comparative study 138
Development and Implementation of the AIDA International Registry for Patients With Undifferentiated Systemic AutoInflammatory Diseases 138
Development and Implementation of the AIDA International Registry for Patients With Still's Disease 138
Age at diagnosis influences the clinical phenotype, treatment strategies and outcomes in patients with giant cell arteritis: results from the observational GCAGE study on a large cohort of 1004 patients 137
Serum Interleukin-36 α as a Candidate Biomarker to Distinguish Behçet’s Syndrome and Psoriatic Arthritis 135
Prevalence and clinical course of SARS-CoV-2 infection in patients with Behçet's syndrome 133
SARS-CoV-2 infection among patients with systemic autoimmune diseases 132
SIRT1 and thrombosis 131
Data-driven subclassification of ANCA-associated vasculitis: model-based clustering of a federated international cohort 131
Clinical profile and evolution of patients with juvenile-onset Behçet’s syndrome over a 25-year period: insights from the AIDA network 126
Clinical features and outcomes of elderly hospitalised patients with chronic obstructive pulmonary disease, heart failure or both 120
Epidemiology of SLE in Italy: an observational study using a primary care database 118
Prescription appropriateness of anti-diabetes drugs in elderly patients hospitalized in a clinical setting: evidence from the REPOSI Register 112
Effectiveness and safety of intravenous immunoglobulin for peripheral neuropathy in EGPA patients: a retrospective study 110
Hospitalisations related to benzodiazepine, Z-drug, and opioid treatment in Italy: a claim on the risks associated with inappropriate use 110
Development and Implementation of the AIDA International Registry for Patients with Non-Infectious Scleritis 109
Comment on: Obstetric antiphospholipid syndrome is not associated with an increased risk of subclinical atherosclerosis. Reply 101
Evidence of subclinical atherosclerosis in Eosinophilic Granulomatosis with Polyangiitis (EGPA) 100
Empowering Patients in the Therapeutic Decision-Making Process: A Glance Into Behçet's Syndrome 97
Retention rate of IL-1 inhibitors in Schnitzler's syndrome 96
Statins, ACE/ARBs drug use, and risk of pneumonia in hospitalized older patients: a retrospective cohort study 95
Pathogenesis of Behçet's Syndrome: Genetic, Environmental and Immunological Factors 91
Prescription of ACE-Is/ARBs in patients with cardio-renal disease: a multicenter retrospective cohort study from the REPOSI registry 85
Unnecessary use of proton pump inhibitors in patients discharged on oral anticoagulant therapy: data from the REPOSI registry 52
ROS‐induced modifications of fibrin clots connect immune responses to atherothrombosis in systemic lupus erythematosus 47
Incidence and prevalence of systemic lupus erythematosus across Italian referral centers and its clinical burden in terms of disease severity, treatment and hospitalization: The ESCULAPIO study 12
Reactive Oxygen Species–Induced Modifications of Fibrin Clots as a Link Between Immune Responses and Atherothrombosis in Systemic Lupus Erythematosus 4
Totale 7.366
Categoria #
all - tutte 22.766
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 22.766


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20216 0 0 0 0 0 0 0 0 0 0 2 4
2021/2022141 0 0 31 9 6 15 2 21 4 5 24 24
2022/2023536 28 91 27 30 21 83 80 28 54 18 33 43
2023/2024607 7 40 48 44 56 90 33 81 33 68 54 53
2024/20252.738 78 250 138 410 624 348 119 120 173 124 146 208
2025/20263.256 367 483 449 307 306 123 403 193 216 247 162 0
Totale 7.366